Zoledronic Acid is a bisphosphonate used to treat osteoporosis and Paget’s disease. It works by inhibiting osteoclast activity, thereby preventing bone resorption and maintaining bone density. Zoledronic Acid is administered intravenously for effective management of bone health. In summary, it is crucial for preventing fractures in at-risk populations.
Zoledronic Acid binds to hydroxyapatite in bone, inhibiting osteoclast-mediated bone resorption and promoting bone density.




